Increase
expectancy
and quality
of life

Our guide is best suited for individuals who are seeking to prolong and enhance their quality of life. It is particularly beneficial for those interested in the latest advancements in anti-aging medicine and technologies that extend human longevity. If you are looking to avoid premature aging, delay the aging process, reduce the signs of aging, or even explore ways to reverse your biological age, this guide provides valuable insights. It is also tailored for those looking to understand how technology can aid the elderly in their daily lives.

We utilized information from official sources of state and international structures, as well as market offerings from manufacturers and service providers. Verylonglife.com does not assume responsibility for the veracity of the information in these sources or for maintaining their relevance over any extended period. The information in this report is provided without any guarantees. Verylonglife.com is not liable for any moral or material harm suffered as a result of using this information.

The safety of new pharmaceuticals and services is evaluated through extensive trials according to FDA standards in the United States or equivalent governmental bodies in other countries before they are introduced to the market. New technologies, goods, and services are monitored by the WHO.

To evaluate the effectiveness of technologies aimed at improving human health and longevity, several key performance indicators (KPIs) are utilized. These KPIs focus on their ability to:

1. Prolong life: Technologies are assessed based on their demonstrated capacity to extend the lifespan of living organisms, as observed in controlled experiments.
2. Enhance rejuvenation: Effectiveness is also measured by the degree to which a technology contributes to the rejuvenation of the body, potentially reversing aspects of biological aging.
3. Lower mortality rates: The success of a technology is partly determined by its ability to decrease overall mortality rates among the populations using it.
4. Decrease aging intensity: Technologies that can demonstrably slow down the processes associated with aging, particularly at the cellular level, are considered effective.
5. Reduce incidence of age-related diseases: A key measure of effectiveness is the extent to which a technology can lower the incidence of age-dependent illnesses such as cardiovascular, metabolic, and other related diseases, thereby contributing to higher quality and longevity of human life.

These indicators help compare and contrast various technologies and interventions, providing a comprehensive understanding of their potential to enhance and extend human life.

Chapter 1. Introduction

Chapter 2. Summary

Chapter 3. How did the market for life extension and quality improvement arise? - Conditions for the emergence of the global market for life extension and quality improvement

Chapter 4. Where is the global market for life extension and quality improvement heading? - Dynamics and trends

Chapter 5. What will happen next in the global market for life extension and quality improvement? - Forecast for the development of the global market for life extension and quality improvement until 2030

Chapter 6. Narrowing the view: the life extension segment

Chapter 7. Narrowing the view: the quality of life improvement segment

List of diagrams

Diagram 1. Life expectancy at birth, 1970-2020, years

Diagram 2. Dynamics of life expectancy in the countries/regions with the longest life expectancy in 1970-2020, years

Diagram 3. Top 5 countries by the best dynamics of life expectancy growth in 1950-2020, years

Diagram 4. Dynamics of life expectancy in Russia, China, Germany, Great Britain and the USA in 1970-2020, years

Diagram 5. Assessment of the impact of factors on life expectancy and human health

Diagram 6. Dynamics of the volume of the global market for extending and improving the quality of life, 2016-2021, billion dollars.

Diagram 7. The average (median) age of the world population 1970-2020, years

Diagram 8. Dynamics and forecast of the number of adults with diabetes in 2000-2045, million people.

Diagram 9. Dynamics of investments in research in the field of regenerative medicine in the world 2018-2021, billion dollars.

Diagram 10. Structure of the market for extending and improving the quality of life by region of the world, 2021

Diagram 11. Structure of the market for extending and improving the quality of life by segment, 2021, %

Diagram 12. Projected growth rates of the global economy 2019-2023, %

Chart 13. Forecast of the volume of the global market for extending and improving the quality of life, 2021-2030, billion dollars.

Diagram 13. Dynamics of the volume of the life extension segment, 2016-2021, billion dollars.

Chart 14. Shares of the Top 5 companies in the life extension segment, 2021, %

Chart 13. Life extension segment volume forecast, 2021-2030, USD billion

Diagram 15. Dynamics of the volume of the quality of life improvement segment, 2016-2021, USD billion

Diagram 16. Shares of the Top 5 companies in the quality of life improvement segment, 2021, %

Diagram 19. Forecast of the volume of the quality of life improvement segment, 2021-2030, billion dollars.

List of tables

Table 1. Top 10 countries by life expectancy in 1970 and 2020, years

Table 2. The most well-known geroprotectors, with proven effect

Table 3. Main directions and measures for state support of active longevity in developed countries.

Table 4. The main types of products and services aimed at prolonging and improving the quality of life.

Table 5. Components of the life extension segment.

Table 6. Top 5 companies in the life extension segment, 2021

Table 7. Prices for products and services of leading companies in the life extension segment, 2022

Table 8. Components of the quality of life improvement segment, 2022

Table 9. Top 5 companies in the quality of life improvement segment, 2021

Table 10. Prices for products and services of the leading companies in the quality of life improvement segment, 2022